CN103919949A - Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis - Google Patents

Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis Download PDF

Info

Publication number
CN103919949A
CN103919949A CN201410174220.6A CN201410174220A CN103919949A CN 103919949 A CN103919949 A CN 103919949A CN 201410174220 A CN201410174220 A CN 201410174220A CN 103919949 A CN103919949 A CN 103919949A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
medicine composition
rheumatoid arthritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410174220.6A
Other languages
Chinese (zh)
Inventor
化果
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410174220.6A priority Critical patent/CN103919949A/en
Publication of CN103919949A publication Critical patent/CN103919949A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis. The composition is composed of the following raw material drugs in parts by weight: 50-70 parts of angelica, 25-40 parts of ligusticum wallichii, 20-40 parts of safflower, 20-40 parts of schizonepeta, 25-40 parts of ramulus mori, 25-40 parts of cortex acanthopanacis, 50-70 parts of radix angenicae pubescentis, 20-40 parts of lycopodium clavatum, 45-65 parts of pawpaw, 20-35 parts of radix clematidis, 20-35 parts of notopterygium root, 20-40 parts of divaricate saposhnikovia root, 20-35 parts of garter snake, 12-18 parts of scorpio, 50-65 parts of shichishit, 40-70 parts of hematoxylon and 10-30 parts of homalomena occulta. The traditional Chinese medicine composition provided by the invention has a good effect on rheumatism and rheumatoid arthriti, the cure rate is 98%, the rheumatism and rheumatoid arthritis is not easy to relapse after being cured, and the traditional Chinese medicine composition is free of toxic side effect.

Description

A kind of Chinese medicine composition that is used for the treatment of rheumatism, rheumatoid arthritis
Technical field
The invention belongs to the field of Chinese medicines, relate to a kind of Chinese medicine composition that is used for the treatment of rheumatism, rheumatoid arthritis and preparation method thereof.
Background technology
In China, the Diseases such as arthritis account for 18% of population, and its sickness rate can reach 20%.Investigation finds, the age, 90% women and 80% male suffered from arthritis in the crowd of over-65s, but in fact the disease such as arthritis belong to blue or green, in, common complaint among the elderly and frequently-occurring disease, this disease has the advantages that relapse rate is high, be difficult for radical cure.According to incompletely statistics, approximately have more than 93% arthritic to be effectively treated, control and do not heal repeatly, be even forced to the edge of paralysis after sb.'s illness took a turn for the worse, severe patient can shorten 10 years life-spans.
From its pathogenesis, arthritis is mainly the arthritis pathological changes causing due to inflammation, infection, wound or other unknown causes, belongs to the disease of rheumatism subject.Suffering from patient's main manifestations is redness and swelling of joints, heat, pain and dysfunction etc.Theory of Chinese medical science thinks, primary disease is to take advantage of due to the empty invasion and attack of body because of imbalance of YIN and YANG, positive QI-insufficiency, cold wind.
Rheumatism, rheumatoid arthritis are two kinds common in arthritis.At present, for the treatment of rheumatism, rheumatoid arthritis, mainly comprise following mode: (1) utilizes Western medicine, from therapeutic effect, Western medicine is rapid-action, good analgesic effect, but long-term taking side effect is more, seriously even damages gastrointestinal function and hepatic and renal function etc., and cannot effect a radical cure, easily recurrence; Once after recurrence, symptom even can increase the weight of; (2) utilize Chinese medicine, although this mode can play certain therapeutical effect, onset is slow, cannot remove very soon the misery of sufferer; (3) utilize Aided Physical therapy, such as methods such as microwave heat therapeutic, acupuncture, massages, the method is applicable to that disease is light, the shorter patient of medical history, and it is not good enough to the heavier patient's curative effect of disease, and same easily recurrence; (4) utilize operation, it has certain radical cure curative effect, but one side expenses of surgical treatment costliness easily develops complications on the other hand in operation process, and dangerous.
Therefore, study novel rapid-action, the treatment rheumatism that cure rate is high, relapse rate is low, the medicine of rheumatoid arthritis has great importance.
Summary of the invention
The drug effect that the present invention is directed to existing treatment rheumatism, rheumatoid arthritis is slow, cure rate is low, relapse rate high-technology problem, and a kind of new treatment rheumatism, the Chinese medicine composition of rheumatoid arthritis are provided.
The object of the invention is to be achieved through the following technical solutions:
The crude drug that the present invention treats the Chinese medicine composition of rheumatism, rheumatoid arthritis consists of:
Preferably, the crude drug that the present invention treats the Chinese medicine composition of rheumatism, rheumatoid arthritis consists of:
Medicated wine prepared by Chinese medicine composition of the present invention, also comprises: yellow wine 1000 weight portions, pure jowar wine 2000 weight portions.
Powder prepared by Chinese medicine composition of the present invention, by the Radix Angelicae Sinensis of specified weight part, Rhizoma Chuanxiong, Flos Carthami, Herba Schizonepetae, Ramulus Mori, Cortex Acanthopancis, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Herba Lycopodii, Fructus Chaenomelis, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Zaocys, Scorpio, seven cuttves, Lignum Sappan and Rhizoma Homalomenae, after mixing after grinding or mixing, grind, make 50-150 order powder, to obtain final product.
The preparation method of the medicated wine of Chinese medicine composition of the present invention, comprise the steps: the Radix Angelicae Sinensis of specified weight part, Rhizoma Chuanxiong, Flos Carthami, Herba Schizonepetae, Ramulus Mori, Cortex Acanthopancis, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Herba Lycopodii, Fructus Chaenomelis, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Zaocys, Scorpio, seven cuttves, Lignum Sappan and Rhizoma Homalomenae, with yellow wine and the airtight immersion of the jowar wine 10-30 days of described parts by weight, to obtain final product.
Preferably, the preparation method of the medicated wine of Chinese medicine composition of the present invention, described immersion natural law is 15-20 days.
The application of Chinese medicine composition of the present invention in the medicine of preparation treatment rheumatism, rheumatoid arthritis.
Medicated wine prepared by Chinese medicine composition of the present invention application in the medicine of preparation treatment rheumatism, rheumatoid arthritis.
Powder prepared by Chinese medicine composition of the present invention application in the medicine of preparation treatment rheumatism, rheumatoid arthritis.
The traditional Chinese medical science think rheumatic, rheumatoid arthritis by positive QI-insufficiency, pathogen easily enter, prolonged illness enters blood, pathogen usually intruding into collateral in protracted disease so that phlegm and blood stasis forms.Treatment is first controlled blood to control wind, and blood is lived wind from going out, and being equipped with invigorating spleen and kidney, the body resistance strengthening and constitution consolidating, dispelling rheumatism is that main medicine cooperation realizes.Solution of the present invention is exactly based on above-mentioned understanding and Therapeutic Principle to rheumatism, Pathogenesis of Rheumatoid Arthritis, and with reference to modern pharmacological research achievement, the natural Chinese medicine compositions of the blood-supplementing blood-nourishing obtaining, blood circulation promoting and blood stasis dispelling, treating blood disorders circulation of qi promoting, dredging the meridian, expelling wind and removing dampness, dephlogistication and promoting nuscle growth.By theory of Chinese medical science prescription, this Chinese medicine composition has embodied entirety and has distinguished control key, has brought into play the effect in treating both the principal and the secondary aspects of a disease at the same time, strong joint, has also strengthened human body resistance against diseases, from truly having played the effect of " strengthening vital QI to eliminate pathogenic factors " treatment of arthritis simultaneously.
Chinese medicine composition of the present invention is not only conceived to joint to the treatment of rheumatism, rheumatoid arthritis, also notes the adjusting of allomeric function, emphasizes that strengthening vital QI to eliminate pathogenic factors is only basic method for the treatment of.Righting should be adjusted benefit liver,spleen,kidney; Eliminating evil should expelling wind and removing dampness, blood circulation promoting and blood stasis dispelling, let out turbid removing toxic substances.
The present invention, compared with existing technical scheme, has following advantage:
Chinese medicine composition of the present invention invigorating blood circulation, wind-damp dispelling, pain relieving be as main, focuses on strengthening the body resistance simultaneously.In wind-damp dispelling pain relieving, focus on treating both the principal and secondary aspects of a disease, can play simultaneously and strengthen internal organs function, make negative and positive coordinated balance, QI and blood is in harmonious proportion unimpeded, the function of strengthening vital QI to eliminate pathogenic factors.By clinical observation, rheumatism, rheumatoid arthritis are had to good effect, cure rate reaches 98%, and is difficult for recurrence more afterwards, has no side effect.
Detailed description of the invention
Following experimental example and embodiment are further explained the present invention.Following examples are only the descriptions to best mode for carrying out the invention, scope of the present invention are not had to any restriction.
Embodiment 1
By Radix Angelicae Sinensis 60g, Rhizoma Chuanxiong 30g, Flos Carthami 30g, Herba Schizonepetae 30g, Ramulus Mori 30g, Cortex Acanthopancis 30g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 60g, Herba Lycopodii 30g, Fructus Chaenomelis 60g, Radix Clematidis 30g, Rhizoma Et Radix Notopterygii 30g, Radix Saposhnikoviae 30g, Zaocys 30g, Scorpio 15g, seven cutter 60g, Lignum Sappan 60g and Rhizoma Homalomenae 15g, with yellow wine 1000g and the airtight immersion of pure jowar wine 2000g 15 days, to obtain final product.
Embodiment 2
By Radix Angelicae Sinensis 60g, Rhizoma Chuanxiong 30g, Flos Carthami 30g, Herba Schizonepetae 30g, Ramulus Mori 30g, Cortex Acanthopancis 30g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 60g, Herba Lycopodii 30g, Fructus Chaenomelis 60g, Radix Clematidis 30g, Rhizoma Et Radix Notopterygii 30g, Radix Saposhnikoviae 30g, Zaocys 30g, Scorpio 15g, seven cutter 60g, Lignum Sappan 60g and Rhizoma Homalomenae 15g, after mixing after grinding or mixing, grind, make 50 order powder, to obtain final product.
Embodiment 3
By Radix Angelicae Sinensis 50g, Rhizoma Chuanxiong 25g, Flos Carthami 20g, Herba Schizonepetae 20g, Ramulus Mori 25g, Cortex Acanthopancis 25g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 50g, Herba Lycopodii 20g, Fructus Chaenomelis 45g, Radix Clematidis 20g, Rhizoma Et Radix Notopterygii 20g, Radix Saposhnikoviae 20g, Zaocys 20g, Scorpio 12g, seven cutter 50g, Lignum Sappan 40g and Rhizoma Homalomenae 10g, with yellow wine 1000g and the airtight immersion of pure jowar wine 2000g 20 days, to obtain final product.
Embodiment 4
By Radix Angelicae Sinensis 70g, Rhizoma Chuanxiong 40g, Flos Carthami 40g, Herba Schizonepetae 40g, Ramulus Mori 40g, Cortex Acanthopancis 40g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 70g, Herba Lycopodii 40g, Fructus Chaenomelis 65g, Radix Clematidis 35g, Rhizoma Et Radix Notopterygii 35g, Radix Saposhnikoviae 40g, Zaocys 35g, Scorpio 18g, seven cutter 65g, Lignum Sappan 70g and Rhizoma Homalomenae 30g, after mixing after grinding or mixing, grind, make 150 order powder, to obtain final product.
Embodiment 5
By Radix Angelicae Sinensis 70g, Rhizoma Chuanxiong 40g, Flos Carthami 40g, Herba Schizonepetae 40g, Ramulus Mori 40g, Cortex Acanthopancis 40g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 70g, Herba Lycopodii 40g, Fructus Chaenomelis 65g, Radix Clematidis 35g, Rhizoma Et Radix Notopterygii 35g, Radix Saposhnikoviae 40g, Zaocys 35g, Scorpio 18g, seven cutter 65g, Lignum Sappan 70g and Rhizoma Homalomenae 30g, after mixing after grinding or mixing, grind, make 100 order powder, to obtain final product.
Embodiment 6
By Radix Angelicae Sinensis 60g, Rhizoma Chuanxiong 30g, Flos Carthami 30g, Herba Schizonepetae 30g, Ramulus Mori 30g, Cortex Acanthopancis 30g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 60g, Herba Lycopodii 30g, Fructus Chaenomelis 60g, Radix Clematidis 30g, Rhizoma Et Radix Notopterygii 30g, Radix Saposhnikoviae 30g, Zaocys 30g, Scorpio 15g, seven cutter 60g, Lignum Sappan 60g and Rhizoma Homalomenae 15g, with yellow wine 1000g and the airtight immersion of pure jowar wine 2000g 18 days, to obtain final product.
Embodiment 7
By Radix Angelicae Sinensis 70g, Rhizoma Chuanxiong 40g, Flos Carthami 40g, Herba Schizonepetae 40g, Ramulus Mori 40g, Cortex Acanthopancis 40g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 70g, Herba Lycopodii 40g, Fructus Chaenomelis 65g, Radix Clematidis 35g, Rhizoma Et Radix Notopterygii 35g, Radix Saposhnikoviae 40g, Zaocys 35g, Scorpio 18g, seven cutter 65g, Lignum Sappan 70g and Rhizoma Homalomenae 30g, with yellow wine 1000g and the airtight immersion of pure jowar wine 2000g 10 days, to obtain final product.
Embodiment 8
By Radix Angelicae Sinensis 60g, Rhizoma Chuanxiong 30g, Flos Carthami 30g, Herba Schizonepetae 30g, Ramulus Mori 30g, Cortex Acanthopancis 30g, Radix Angelicae Dahuricae (Radix Heraclei Scabridi) 60g, Herba Lycopodii 30g, Fructus Chaenomelis 60g, Radix Clematidis 30g, Rhizoma Et Radix Notopterygii 30g, Radix Saposhnikoviae 30g, Zaocys 30g, Scorpio 15g, seven cutter 60g, Lignum Sappan 60g and Rhizoma Homalomenae 15g, with yellow wine 1000g and the airtight immersion of pure jowar wine 2000g 30 days, to obtain final product.
Experimental example: the research of Chinese medicine composition of the present invention to rheumatism, rheumatoid arthritis treatment effect
Experimental example 1
Puyang County, Henan Province Ms Zhang, 65 years old, suffer from rheumatoid arthritis more than ten years, Relapse rate outbreak, and day by day serious, finger-joint distortion pain cannot be stood.Take after two courses for the treatment of of medicated wine of pharmaceutical composition of the present invention, slight illness alleviates, finger segments swelling, numb disappearance; After eight courses for the treatment of, fully recover, not recurrence.
Experimental example 2
Qingfeng County, Henan Province Mrs Guo, suffers from rheumatoid arthritis 8 years, and often arthralgia is stiff, arthroncus, regular heating, 38 DEG C-39 DEG C of body temperature, both hands food, in, thumb moderate distortion, two elbow joinies swell and ache, not tensible, health is become thin.Take after two courses for the treatment of of powder of pharmaceutical composition of the present invention, arthralgia disappears; After seven courses for the treatment of, fully recover, consolidate now life normal, not recurrence after two courses for the treatment of.
Experimental example 3
The Puyang granddaughter scholar of Henan Province, 52 years old, suffer from rheumatic arthritis, multiple joints of whole body symmetry swells and ache 2 years, increases the weight of 4 months.Both hands proximal interphalangeal joint, both hands metacarpophalangeal joints obvious tumefaction and tenderness, two wrists, duplex arthroncus, left side is obvious, stretches 170 degree, and tenderness is obvious, both shoulders can not be gone up act walking disorder, when serious symptom, is unable to leave the bed.Take after three courses for the treatment of of medicated wine of pharmaceutical composition of the present invention, can be freely movable, squat down freely, movable normal, now rehabilitation.
Experimental example 4
Liaocheng of Shandong Province Mr. Ge, 46 years old, suffer from rheumatoid arthritis, whole body arthralgia more than 3 years, increases the weight of 1 year.Before 3 years because there is multiple joints of whole body pain, numb pain in residence humidity.After half a year, gradually and wrist, knee joint, ankle joint and toes joint, all become symmetry pain.Can not get up closely over the past half year, stand up difficulty.Take after three courses for the treatment of of medicated wine of pharmaceutical composition of the present invention, above symptom alleviates gradually, can walk freely, and arthralgia disappears, two arms can go up lift excessive, elbow joint is freely extensible, knee joint bending is normal, General Symptoms disappears substantially, again after treatment a period of time, now fully recovers.
Experimental example 5
In order to show the therapeutic effect of this Chinese medicine composition to rheumatism, rheumatoid arthritis, the present invention is through 107 routine system clinical observations, and records its medical history, the state of an illness, age and former Therapeutic Method and carry out efficacy experiment.
Medicated wine prepared by medication: embodiment 1 is taken 2 times every day, sooner or later after meal respectively once, and each about 30mL (0.5 liang); The course for the treatment of: 15 days be a course for the treatment of.
Rheumatism, patient with rheumatoid arthritis 107 people, show as arthroncus mostly, even distortion, what have reaches knee joint, elbow joint gross distortion, has also occurred the limited situation of taking action, and with serious pain and inflammation performance, morning deadlock.In these patients, what the course of disease was long reaches 12 years, and what the course of disease was shorter is also 6 months.Most importantly, more than 80% sufferer checks in rheumatoid factor and shows the positive, and erythrocyte sedimentation rate increases to some extent to some extent.
Clinical test results shows, only uses the medicated wine of 1 Chinese medicine composition of the present invention, and for the patient who occurs joint deformity, pain symptom obviously stops, and takes action limitedly obviously to alleviate, and check erythrocyte sedimentation rate all declines, and rheumatoid factor also transferred feminine gender to after 15 days.The patient that 5% disease is lighter can reach the effect of curing 2 courses for the treatment of.According to statistics, use after 4 courses for the treatment of, above-mentioned 107 routine patients reach 98% cure rate, and all the other 2% effective or improvements, without invalid situation (be shown in table 1).
The criterion of clinical therapeutic efficacy is: clinical cure: pain disappears completely, and swelling disappears, and after joint deformity, is restored, and RF turns out cloudy; Effective: pain disappears, only, after Changes in weather or fatigue, occasionally there is hypodynia, swelling disappears, and RF turns out cloudy; Take a turn for the better: original state of an illness alleviates to some extent; Invalid: symptom Signs is unchanged.
Table 1
In above-mentioned clinical trial, we have done inspection record to the hematuria routine before and after patient's medication, hepatic and renal function, electrocardiogram etc., contrast no abnormally, and the medicated wine of this Chinese medicine composition has no side effect as seen.
Experimental example 6
In order to show the therapeutic effect of this Chinese medicine composition to rheumatism, rheumatoid arthritis, the present invention is through 102 routine system clinical observations, and records its medical history, the state of an illness, age and former Therapeutic Method and carry out efficacy experiment.
Powder prepared by medication: embodiment 2 is taken 2 times every day, sooner or later after meal respectively once, and each about 25g; The course for the treatment of: 15 days be a course for the treatment of.
Rheumatism, patient with rheumatoid arthritis 102 people, show as arthroncus mostly, even distortion, what have reaches knee joint, elbow joint gross distortion, has also occurred the limited situation of taking action, and with serious pain and inflammation performance, morning deadlock.In these patients, what the course of disease was long reaches 10 years, and what the course of disease was shorter is also 5 months.Most importantly, more than 80% sufferer checks in rheumatoid factor and shows the positive, and erythrocyte sedimentation rate increases to some extent to some extent.
Clinical test results shows, only uses the powder of 1 Chinese medicine composition of the present invention, and for the patient who occurs joint deformity, pain symptom obviously stops, and takes action limitedly obviously to alleviate, and check erythrocyte sedimentation rate all declines, and rheumatoid factor also transferred feminine gender to after 15 days.The patient that 5% disease is lighter can reach the effect of curing 2 courses for the treatment of.According to statistics, use after 4 courses for the treatment of, above-mentioned 102 routine patients reach 98% cure rate, and all the other 2% effective or improvements, without invalid situation (be shown in table 2).
The criterion of clinical therapeutic efficacy is: clinical cure: pain disappears completely, and swelling disappears, and after joint deformity, is restored, and RF turns out cloudy; Effective: pain disappears, only, after Changes in weather or fatigue, occasionally there is hypodynia, swelling disappears, and RF turns out cloudy; Take a turn for the better: original state of an illness alleviates to some extent; Invalid: symptom Signs is unchanged.
Table 2
In above-mentioned clinical trial, we have done inspection record to the hematuria routine before and after patient's medication, hepatic and renal function, electrocardiogram etc., contrast no abnormally, and the powder of this Chinese medicine composition has no side effect as seen.
Obviously, above-described embodiment is only for example is clearly described, and the not restriction to embodiment.For those of ordinary skill in the field, can also make other changes in different forms on the basis of the above description.Here without also giving exhaustive to all embodiments.And the apparent variation of being extended out thus or variation are still among the protection domain in the invention.

Claims (9)

1. a Chinese medicine composition for the treatment of rheumatism, rheumatoid arthritis, is characterized in that, the crude drug of said composition consists of:
2. Chinese medicine composition according to claim 1, is characterized in that, the crude drug of said composition consists of:
3. the medicated wine that prepared by the arbitrary described Chinese medicine composition of claim 1-2, is characterized in that, also comprises: yellow wine 1000 weight portions, pure jowar wine 2000 weight portions.
4. the powder that prepared by the arbitrary described Chinese medicine composition of claim 1-2, it is characterized in that, by the Radix Angelicae Sinensis of specified weight part, Rhizoma Chuanxiong, Flos Carthami, Herba Schizonepetae, Ramulus Mori, Cortex Acanthopancis, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Herba Lycopodii, Fructus Chaenomelis, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Zaocys, Scorpio, seven cuttves, Lignum Sappan and Rhizoma Homalomenae, after mixing after grinding or mixing, grind, make 50-150 order powder, to obtain final product.
5. the preparation method of medicated wine described in claim 3, it is characterized in that, comprise the steps: the Radix Angelicae Sinensis of specified weight part, Rhizoma Chuanxiong, Flos Carthami, Herba Schizonepetae, Ramulus Mori, Cortex Acanthopancis, Radix Angelicae Dahuricae (Radix Heraclei Scabridi), Herba Lycopodii, Fructus Chaenomelis, Radix Clematidis, Rhizoma Et Radix Notopterygii, Radix Saposhnikoviae, Zaocys, Scorpio, seven cuttves, Lignum Sappan and Rhizoma Homalomenae, with yellow wine and the airtight immersion of the jowar wine 10-30 days of specified weight part, to obtain final product.
6. preparation method according to claim 5, is characterized in that, described immersion natural law is 15-20 days.
7. the application of the arbitrary described Chinese medicine composition of claim 1-2 in the medicine of preparation treatment rheumatism, rheumatoid arthritis.
8. the application of medicated wine in the medicine of preparation treatment rheumatism, rheumatoid arthritis described in claim 3.
9. the application of powder in the medicine of preparation treatment rheumatism, rheumatoid arthritis described in claim 4.
CN201410174220.6A 2014-04-28 2014-04-28 Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis Pending CN103919949A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410174220.6A CN103919949A (en) 2014-04-28 2014-04-28 Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410174220.6A CN103919949A (en) 2014-04-28 2014-04-28 Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis

Publications (1)

Publication Number Publication Date
CN103919949A true CN103919949A (en) 2014-07-16

Family

ID=51138491

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410174220.6A Pending CN103919949A (en) 2014-04-28 2014-04-28 Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis

Country Status (1)

Country Link
CN (1) CN103919949A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055728A (en) * 2015-09-01 2015-11-18 齐然 Chinese herb composition for treating rheumatism
CN105754802A (en) * 2016-05-12 2016-07-13 枣阳市灵鹿酒业有限公司 Land-sealed yellow wine capable of alleviating rheumatic osteodynia
CN105853955A (en) * 2016-04-01 2016-08-17 杨志全 Medicine for treating rheumatoid arthritis
CN114699483A (en) * 2022-04-26 2022-07-05 昆明梵之源健康管理有限公司 Externally applied medicinal liquor for removing obstruction of qi and removing dampness

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1919279A (en) * 2006-04-21 2007-02-28 黄月红 Plaster with wind and cold dispelling, toxin removing and clots absorbing function, and its preparing process
CN102188595A (en) * 2011-05-16 2011-09-21 化果 Chinese medicine composition for treating arthritis and preparation method thereof
CN102293943A (en) * 2011-09-16 2011-12-28 娄峰 Medicinal liquor for treating rheumatism and preparation method
CN102824393A (en) * 2012-08-19 2012-12-19 甘肃省中医院 Pharmaceutical composition for dispelling wind, relieving pain, dispelling cold, and removing dampness and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1919279A (en) * 2006-04-21 2007-02-28 黄月红 Plaster with wind and cold dispelling, toxin removing and clots absorbing function, and its preparing process
CN102188595A (en) * 2011-05-16 2011-09-21 化果 Chinese medicine composition for treating arthritis and preparation method thereof
CN102293943A (en) * 2011-09-16 2011-12-28 娄峰 Medicinal liquor for treating rheumatism and preparation method
CN102824393A (en) * 2012-08-19 2012-12-19 甘肃省中医院 Pharmaceutical composition for dispelling wind, relieving pain, dispelling cold, and removing dampness and preparation method thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055728A (en) * 2015-09-01 2015-11-18 齐然 Chinese herb composition for treating rheumatism
CN105853955A (en) * 2016-04-01 2016-08-17 杨志全 Medicine for treating rheumatoid arthritis
CN105754802A (en) * 2016-05-12 2016-07-13 枣阳市灵鹿酒业有限公司 Land-sealed yellow wine capable of alleviating rheumatic osteodynia
CN114699483A (en) * 2022-04-26 2022-07-05 昆明梵之源健康管理有限公司 Externally applied medicinal liquor for removing obstruction of qi and removing dampness

Similar Documents

Publication Publication Date Title
CN103211932B (en) Traditional Chinese medicine composition for treating rheumatism
CN103919949A (en) Traditional Chinese medicine composition for treating rheumatism and rheumatoid arthritis
CN103505659A (en) Chinese proprietary medicine for treating rheumatoid arthritis
CN104771740A (en) Traditional Chinese medicine composition for treating rheumatic arthritis
CN102058802A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis
CN106039014A (en) Plaster for treating gout and preparation method thereof
CN102475868A (en) Anti-rheumatism medicinal liquor
CN108295128B (en) Traditional Chinese medicine compound preparation for treating rheumatoid arthritis and preparation method thereof
CN101062363A (en) Chinese traditional medicine combination for activating blood circulation and treating thrombus
CN103099869B (en) Traditional Chinese medicine wine for treating blood obstructing lubar intervertebral disc protrusion
CN1843421A (en) Rheumatoid disease treating medicine
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN103735647A (en) Medicated wine for treating chronic infectious arthritis
CN103110780B (en) External-use traditional Chinese medicine preparation for treating chronic bursitis
CN102872252B (en) Medicinal composition for treating rheumatic pain
CN105687912A (en) Traditional Chinese medicinal composition for treating gout
CN104758725A (en) Traditional Chinese medicine composition for treating articular effusion in knee joints
CN104825916A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN103494887A (en) Chinese medicine composition for treating knee arthritis and preparation method thereof
CN103656378A (en) Traditional Chinese medicine agent for treatment of acute gouty arthritis
CN103751293A (en) Traditional Chinese medicinal composition for treating chronic nephritis
CN103638440A (en) Traditional Chinese medicine for treating nonbacterial prostatitis
CN103316133B (en) Medicine for treating lame impediment
CN102861195B (en) Drug composition for treating rheumatism pain
CN105125978A (en) Traditional Chinese medicine preparation for treating rheumatic arthritis and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140716

WD01 Invention patent application deemed withdrawn after publication